ADT Biotech
ADT Biotech is a Malaysia-headquartered molecular diagnostics distributor and proprietary IVD kit manufacturer, distributing LyteStar and SpinStar branded RT-PCR assays alongside partner brands across 15+ Asia Pacific markets through subsidiaries in Malaysia, India, Korea, and Singapore.
- Company typePrivate
- Founded2010
- HeadquartersPetaling Jaya, Malaysia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What ADT Biotech does
ADT Biotech is a privately held molecular diagnostics distributor and proprietary IVD kit manufacturer founded in 2010 and headquartered in Petaling Jaya (Kuala Lumpur), Malaysia. The company operates through wholly-owned regional subsidiaries in India (ADT India, established 2013), South Korea (ADT Korea, 2017), and Singapore (SDT Molecular, 2017), distributing its own LyteStar RT-PCR detection kits and SpinStar nucleic acid extraction kits alongside an exclusive partner-brand portfolio that includes GeneProof, PathoNostics, PathoFinder, Master Diagnostica, UNIMA, RBC Bioscience, Bio Molecular Systems, and Qnostics across 15+ Asia Pacific markets.
Its core technical platform is built on real-time PCR and syndromic multiplex PCR, with proprietary LyteStar assays covering SARS-CoV-2, influenza, dengue, arboviruses (Zika/Chikungunya/Dengue), MERS-CoV, HCV genotyping, HIV-2, Leptospira, scrub typhus, TB/NTM, and enterovirus HFMD — developed under ISO 13485:2016 quality management and registered country-by-country through MDA Malaysia, Thai FDA, CDSCO India, Taiwan FDA, and Australia's ARTG. ADT complements these wet-lab kits with laboratory automation hardware (MagCore Plus II extractor, Mic qPCR cycler, Myra liquid handler) and a point-of-care saliva antigen test (UNIMA Find). A smartphone application using a neural-network-based image analysis is integrated into the UNIMA Find product as a partner-provided capability.
The business model is primarily a regional specialty distribution model combined with proprietary kit manufacturing under the LyteStar and SpinStar brands. Revenue is generated through one-time sales of branded kits and partner products, hardware sales of laboratory automation equipment, and bundled technical support and training services — all priced via quote-based engagement with sales representatives rather than public list pricing. Customers are diagnostic and life science laboratories, point-of-care facilities, and laboratory automation customers, with anchor validation/contract relationships including the Malaysian Ministry of Health, the Indian Council of Medical Research (ICMR), and the Institute for Medical Research (IMR) Malaysia. The company holds BioNexus Status from the Malaysian Bioeconomy Corporation and ISO 13485:2016 certification, and pursues a sales-led GTM with dedicated field sales teams across regional subsidiaries and exclusive channel partner arrangements with its principals.
ADT Biotech firmographics
Firmographics- Name
- ADT Biotech
- Legal name
- ADT Biotech
- Website
- https://adt-biotech.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ADT Biotech is a Malaysia-headquartered molecular diagnostics distributor and proprietary IVD kit manufacturer, distributing LyteStar and SpinStar branded RT-PCR assays alongside partner brands across 15+ Asia Pacific markets through subsidiaries in Malaysia, India, Korea, and Singapore.
- Ownership category
- akta.pro rank
ADT Biotech industry classification
Industry- Product category
- Molecular Diagnostics Distribution & IVD Products
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Biologics & Biosimilars Distributors (HLAIAJAH)
Keywords
Where ADT Biotech is headquartered
LocationHeadquarters
- HQ city
- Petaling Jaya
- HQ country
- Malaysia
- HQ region
- Asia
Offices4 records
Markets served
ADT Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Distribution of IVD Products: ADT Biotech generates revenue by distributing proprietary LyteStar and SpinStar branded diagnostic kits, as well as acting as regional distributor for partner brands including GeneProof, PathoNostics, PathoFinder, and Master Diagnostica products throughout Asia Pacific markets.
- Laboratory Automation Equipment: Distribution of laboratory automation equipment including nucleic acid extractors (MagCore), PCR instruments (Mic qPCR), and liquid handling systems (Myra) from partner manufacturers.
- Technical Support and Training Services: Provides technical support, application support, and training services to customers as part of their value proposition to partners, though primarily bundled with product distribution.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
ADT Biotech product offering
Product offeringCore offering
ADT Biotech is a molecular diagnostics distributor and solution provider that develops and sells its own LyteStar™ RT-PCR detection kits and SpinStar™ nucleic acid extraction kits (ISO 13485 compliant), while acting as exclusive regional distributor for partner brands GeneProof, PathoNostics, PathoFinder, Master Diagnostica, UNIMA, RBC Bioscience, and Bio Molecular Systems across Asia Pacific markets. Its offering spans IVD test kits, point-of-care rapid tests, nucleic acid extractors, qPCR cyclers, and liquid handling systems for clinical and research laboratories and government health institutions.
Product overview
ADT Biotech is a molecular diagnostics distributor and solution provider operating as a multi-brand portfolio model. The company resells and distributes its own LyteStar™ brand of RT-PCR detection kits (including COVID-19, influenza, dengue, arbovirus, MERS-CoV, HCV genotyping, HIV-2, Leptospira, Scrub Typhus, TB/NTM, and HFMD kits) alongside partner brands including GeneProof (CE-IVD certified PCR kits for infectious diseases), PathoNostics (fungal detection including AsperGenius, DermaGenius, PneumoGenius, MucorGenius), PathoFinder (syndromic multiplex panels including RespiFinder, GastroFinder, MeningoFinder, STD-Finder), and Master Diagnostica (DNA Flow technology for sepsis, AMR, HPV, STDs). The portfolio also includes SpinStar™ extraction kits, lab automation equipment (MagCore® Plus II extractor, Mic qPCR cycler, Myra liquid handler), and UNIMA Find point-of-care technology. ADT Biotech focuses on molecular diagnostics with emphasis on real-time PCR technologies for clinical laboratory applications across Asia Pacific markets.
Differentiator
Problem solved
Functional benefit
Brands
- LyteStar: Detection kits developed in compliance with ISO 13485 for emerging needs and specific customer requirements in ADT's home markets, including COVID-19, influenza, dengue, MERS-CoV, HCV, HIV-2, Leptospira, Scrub Typhus, TB/NTM, and enterovirus kits.
- SpinStar
Products and services
- LyteStar™ Detection Kits Own-brand multiplex RT-PCR detection kits developed in compliance with ISO 13485 for emerging diagnostic needs. Includes kits for SARS-CoV-2, influenza, dengue, arboviruses (ZIKV/ChikV/Dengue), MERS-CoV, HCV genotyping, HIV-2, Leptospira, Scrub Typhus, TB/NTM, and Enterovirus HFMD typing. Used by clinical and reference laboratories for infectious disease molecular diagnostics.
- SpinStar™ Extraction Kits Nucleic acid extraction kits including Viral Nucleic Acid Kit, Viral Nucleic Acid Kit ULTRA, Pathogen Nucleic Acid Kit, Total DNA Extraction Kit, and VNAplus Mix. Designed for molecular diagnostic downstream applications using a 4-step spin column procedure (lyse, bind, wash, elute). For clinical and research laboratories performing nucleic acid purification prior to PCR detection.
- GeneProof Realtime PCR Detection Kits CE-IVD certified ready-to-use real-time PCR systems distributed under the principal partnership with GeneProof, covering infectious diseases, genetic and oncogenetic markers, pharmacogenetics, thrombotic mutations, and prenatal diagnostics. Features UNG contamination prevention, internal controls, and broad real-time PCR instrument compatibility. For clinical laboratories and genetic diagnostics providers.
- PathoNostics Fungal Detection Kits CE-IVD certified diagnostic kits distributed under the principal partnership with PathoNostics for fungal infections and resistance detection. Includes AsperGenius (Aspergillus species + azole resistance markers L98H/TR34/TR46/Y121F/T289A), DermaGenius 2.0 (dermatophytosis), PneumoGenius (Pneumocystosis + DHPS resistance), and MucorGenius (mucormycosis). For clinical mycology laboratories and infectious disease departments.
- PathoFinder Syndromic Multiplex PCR Panels SmartFinder technology-enabled single-tube multiplex amplification in real-time (SMART) of up to 24 infectious pathogens, distributed under the PathoFinder principal partnership. Includes RespiFinder 2SMART (24 respiratory pathogens incl. SARS-CoV-2), GastroFinder 2SMART (18 GI pathogens), MeningoFinder 2SMART (22 CNS pathogens), and STD-Finder 2SMART (9 STD pathogens). For syndromic testing in hospital laboratories and reference centers.
- Master Diagnostica DNA Flow Technology Kits Membrane-based reverse dot blot hybridization platform distributed under the Master Diagnostica principal partnership, providing rapid analyses for sepsis, antimicrobial resistance, HPV, STDs, bacterial CNS infections, and tick-borne bacterial infections. Products include Sepsis Flow Chip (Gram+/Gram-/Fungi with resistance markers), AMR Direct Flow Chip (20 resistance genes), HPV Direct Flow Chip (36 genotypes), STD Direct Flow Chip (11 pathogens), Bacterial CNS Flow Chip (9 bacteria + Cryptococcus), and Tick-borne Bacteria Flow Chip (7 species). For hospital and reference laboratories.
- UNIMA Find SARS-CoV-2 Point-of-Care Test Saliva-based agglutination immunoassay for detection of SARS-CoV-2 Spike S1 protein antigen using latex microparticles conjugated with recombinant VNAR single-domain shark antibody. Delivers results in 5 minutes via smartphone application with Xplora image analysis and neural network algorithm. Claims 97% sensitivity and 98% specificity. Enables non-invasive home or point-of-care use without requiring specialized laboratory infrastructure. For point-of-care operators, healthcare facilities, and population-level screening programs.
- RBC Bioscience MagCore® Plus II Nucleic Acid Extractor Automated bench-top workstation distributed under the RBC Bioscience principal partnership for fast and high-yield nucleic acid purification from molecular diagnostic, biological, clinical, and forensic sample types. Processes 1-16 samples simultaneously with built-in programs, real-time mobile monitoring, and full traceability. For clinical and research laboratories seeking to scale throughput and automate routine nucleic acid preparation.
- Bio Molecular Systems Mic qPCR Cycler Real-time PCR cycler distributed under the Bio Molecular Systems principal partnership using patented magnetic induction heating and fan-forced air cooling. Available in 2 or 4 channel models with independent high intensity LED, photodetector, and filter set per channel. Fixed optical path eliminates optical alignment or calibration requirements. For clinical and research laboratories performing real-time PCR.
- Bio Molecular Systems Myra Liquid Handling System Automated liquid handling system distributed under the Bio Molecular Systems principal partnership, designed for seamless workflow integration with the Mic qPCR cycler. Provides <10% accuracy and precision for 1 µL pipetting volumes with multi-dispense and tip-reuse optimization. For laboratories automating PCR setup and routine liquid handling workflows.
Quantifiable outcome
- 97% sensitivity and 98% specificity for SARS-CoV-2 detection using UNIMA Find technology
- +2 more outcomes
Companies that use ADT Biotech
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
ADT Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ADT Biotech partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and secondary.
- GeneProofcoreGeneProof is a key principal partner providing extensive range of fully validated CE IVD certified real-time PCR detection kits for infectious diseases, genetic and oncogenic markers. ADT distributes GeneProof products across Asia Pacific markets including Malaysia, India, Thailand, and other regulated markets.
- PathoNosticscorePathoNostics provides CE-IVD certified real-time PCR kits for fungal infections with resistance detection capabilities including AsperGenius, DermaGenius, PneumoGenius, and MucorGenius products. Products registered in Malaysia, India, Taiwan, and Australia.
- PathoFindercorePathoFinder offers syndromic multiplex PCR panels using SmartFinder technology enabling single-tube multiplex amplification of up to 24 pathogens. Products include RespiFinder, GastroFinder, MeningoFinder, and STD-Finder panels registered across multiple Asian markets.
- Master DiagnosticasecondaryMaster Diagnostica provides DNA Flow Technology platform for rapid analyses in membrane-based reverse dot blot hybridization. Products include Sepsis Flow Chip, AMR Direct Flow Chip, HPV Direct Flow Chip, STD Direct Flow Chip, Bacterial CNS Flow Chip, and Tick-borne Bacteria Flow Chip.
- UNIMAsecondaryUNIMA provides Find rapid technology for point-of-care detection of SARS-CoV-2 antigen in saliva using smartphone application for results interpretation. Enables 5-minute detection with 97% sensitivity and 98% specificity.
- RBC BiosciencesecondaryRBC Bioscience provides MagCore automated nucleic acid extractors including MagCore Plus II for fast and high-yield purification from various clinical sample types. ADT distributes these instruments as part of laboratory automation portfolio.
- Bio Molecular SystemssecondaryBio Molecular Systems provides Mic qPCR cycler using patented magnetic induction technology for fastest qPCR results, and Myra liquid handling system for automated PCR setup. ADT distributes these instruments across Asia Pacific.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
ADT Biotech competitors and assessment
Company assessmentBroad incumbents
- bioMérieux: Global IVD leader with extensive microbiology and molecular diagnostics portfolio (BioFire FilmArray, VITEK) and strong APAC commercial footprint. Competes with ADT across syndromic panels and infectious disease testing but at significantly larger scale and broader scope.
- Hologic: Global diagnostics company with Panther molecular system and large women's health/virology menu. Competes in APAC molecular diagnostics with broader portfolio and stronger regulatory and commercial infrastructure than ADT.
- Qiagen: Global sample technologies and molecular diagnostics leader with the QIAstat-Dx syndromic platform and broad PCR portfolio. Prior employer of ADT's founder and senior technical staff; overlaps with ADT's product categories at much larger scale.
Direct peers
- ELITech Group: European IVD company distributing molecular diagnostics, clinical chemistry, and microbiology products through a multi-country distributor network. Closely mirrors ADT's multi-brand distribution model with partner principals across multiple regions.
- R-Biopharm: German molecular diagnostics and clinical chemistry company distributing IVD kits globally, including through regional partners. Comparable mid-sized European-headquartered MDx specialist with multi-jurisdiction product registrations.
- Cepheid (Danaher): Molecular diagnostics leader behind the GeneXpert system and Xpert test menu (TB, sexual health, respiratory, virology). Operates a comparable molecular diagnostics product category and competes head-to-head for government and clinical lab tenders across APAC.
- AusDiagnostics: Australian molecular diagnostics manufacturer of multiplexed PCR systems (Tosoh/MT-PCR) for infectious disease. Comparable APAC-focused MDx specialist with similar product positioning in syndromic and routine pathogen testing.
- SD Biosensor: Korea-based IVD manufacturer with global distribution of molecular and rapid diagnostic tests, including COVID-19, influenza, and tropical disease kits. Comparable product breadth and APAC distribution model to ADT's LyteStar plus partner-brand stack.
- SpeeDx: Australia-based molecular diagnostics company focused on infectious disease and antimicrobial resistance PCR assays. Comparable regional MDx player operating in the same APAC geography and overlapping product categories.
- Seegene: Korea-headquartered molecular diagnostics company developing multiplex PCR assays and syndromic panels (respiratory, GI, meningitis, STI) — directly comparable to PathoFinder SmartFinder products distributed by ADT. Both target Asian clinical lab markets with syndromic testing offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ADT Biotech social profiles
Digital presenceADT Biotech compliance and trust
Trust signalCompliance3 records
ADT Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
ADT Biotech leadership team
Management profileNumber of profiles
Profiles10 records
ADT Biotech subsidiaries and ownership
Company hierarchySubsidiaries4 records
ADT Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ADT Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ADT Biotech
What does ADT Biotech do?
ADT Biotech is a molecular diagnostics distributor and solution provider that develops and sells its own LyteStar™ RT-PCR detection kits and SpinStar™ nucleic acid extraction kits (ISO 13485 compliant), while acting as exclusive regional distributor for partner brands GeneProof, PathoNostics, PathoFinder, Master Diagnostica, UNIMA, RBC Bioscience, and Bio Molecular Systems across Asia Pacific markets. Its offering spans IVD test kits, point-of-care rapid tests, nucleic acid extractors, qPCR cyclers, and liquid handling systems for clinical and research laboratories and government health institutions.
Is ADT Biotech a public or private company?
ADT Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ADT Biotech founded?
ADT Biotech was founded in 2010. It employs 1 to 10 people.
Where is ADT Biotech based?
ADT Biotech is headquartered in Petaling Jaya, Malaysia, in the Asia region.
How does ADT Biotech make money?
Three revenue lines are on record. Distribution of IVD Products are the primary driver. The others are laboratory Automation Equipment and technical Support and Training Services.
Who are ADT Biotech's main competitors?
Broad incumbents on record are bioMérieux, Hologic and Qiagen. Direct peers are ELITech Group, R-Biopharm, Cepheid (Danaher), AusDiagnostics, SD Biosensor, SpeeDx and Seegene.
Does ADT Biotech have an API?
No public API is recorded for ADT Biotech.
What industry is ADT Biotech in?
ADT Biotech's product category is Molecular Diagnostics Distribution & IVD Products. Its primary akta.pro industry code is HLAIAJAH, Biologics & Biosimilars Distributors. Its NAICS code is 325413 and its SIC code is 5047.